Valuation dashboard for Aspire Biopharma Holdings, Inc. (ASBP) with P/E N/A, P/B -37.44, EV/EBITDA -20.93 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management.
Analysis Summary
Trailing-twelve-month margins: gross margin -1.9%, operating margin -3120.2%, net margin -3947.3%.
At the current price of $8.58, ASBP has negative trailing earnings (P/E not meaningful) and an ROE of 383.93%. Market capitalisation stands at $1M.
Balance sheet quality for ASBP: current ratio of 0.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -37.44 |
| EV / EBITDA | -20.93 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ASBP | Aspire Biopharma Holdings, Inc. | 383.9% | |||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $8.58 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 383.93% |
| Return on Invested Capital | 395.26% |
| Return on Assets | -1865.68% |
| Gross Margin | -1.87% |
| Operating Margin | -312016.95% |
| Net Margin | -394725.06% |
Related companies: ANNA · BOCN · CAUD · CHAA · CSLM · FIAC · GAMC
Explore sector: Healthcare · Biotechnology
More sections of ASBP: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks